FDA Import Refusal AEK-1204773-2/11/1 — LABORATORIO PHARMALIFE
The FDA refused shipment AEK-1204773-2/11/1 from LABORATORIO PHARMALIFE (Mexico) on Jun 28, 2022. The refused product falls under Drugs and Biologics — ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Jun 28, 2022
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY28 ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75